The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
IBD is linked to an increase in oxygen-tolerant bacteria that travel from the mouth and take up residence in the gut ...
Individuals with CD who received treatment with biologics preoperatively have improved endoscopic outcomes when switching to a different biologic postoperatively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback